表紙
市場調查報告書

焦慮症治療藥的全球市場

Anxiety Disorders

出版商 Global Industry Analysts, Inc. 商品編碼 912775
出版日期 內容資訊 英文 151 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
焦慮症治療藥的全球市場 Anxiety Disorders
出版日期: 2019年10月01日內容資訊: 英文 151 Pages
簡介

全球焦慮症治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 簡介·調查手法·調查範圍

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球焦慮症治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ABBOTT LABORATORIES
  • ALLERGAN PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • NOVEN PHARMACEUTICALS, INC.
  • PFIZER, INC
  • shionogi製藥
  • 大日本住友製藥

第5章 調查資料

目錄
Product Code: MCP-6392

Anxiety Disorders market worldwide is projected to grow by US$1.3 Billion, driven by a compounded growth of 2.7%. Antidepressants, one of the segments analyzed and sized in this study, displays the potential to grow at over 3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.6 Billion by the year 2025, Antidepressants will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 2.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$49.7 Million to the region's size and clout in the next 5 to 6 years. Over US$37.3 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Antidepressants will reach a market size of US$204.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 4.3% over the next couple of years and add approximately US$371.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Abbott Laboratories, Inc.; Allergan PLC; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Noven Pharmaceuticals, Inc.; Pfizer, Inc.; Shionogi & Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Anxiety Disorders Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Anxiety Disorders Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Anxiety Disorders Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Anxiety Disorders Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Antidepressants (Therapeutic Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Antidepressants (Therapeutic Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Antidepressants (Therapeutic Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Benzodiazepines (Therapeutic Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Benzodiazepines (Therapeutic Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Benzodiazepines (Therapeutic Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Other Therapeutic Types (Therapeutic Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Other Therapeutic Types (Therapeutic Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Other Therapeutic Types (Therapeutic Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Anxiety Disorders Market Share (in %) by Company: 2019 & 2025
    • TABLE 13: United States Anxiety Disorders Market Estimates and Projections in US$ Million by Therapeutic Type: 2018 to 2025
    • TABLE 14: Anxiety Disorders Market in the United States by Therapeutic Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 15: United States Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 16: Canadian Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025
    • TABLE 17: Canadian Anxiety Disorders Historic Market Review by Therapeutic Type in US$ Million: 2009-2017
    • TABLE 18: Anxiety Disorders Market in Canada: Percentage Share Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025
  • JAPAN
    • TABLE 19: Japanese Market for Anxiety Disorders: Annual Sales Estimates and Projections in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 20: Anxiety Disorders Market in Japan: Historic Sales Analysis in US$ Million by Therapeutic Type for the Period 2009-2017
    • TABLE 21: Japanese Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 22: Chinese Anxiety Disorders Market Growth Prospects in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 23: Anxiety Disorders Historic Market Analysis in China in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 24: Chinese Anxiety Disorders Market by Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Anxiety Disorders Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 25: European Anxiety Disorders Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 26: Anxiety Disorders Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 27: European Anxiety Disorders Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 28: European Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018-2025
    • TABLE 29: Anxiety Disorders Market in Europe in US$ Million by Therapeutic Type: A Historic Review for the Period 2009-2017
    • TABLE 30: European Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 31: Anxiety Disorders Market in France by Therapeutic Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 32: French Anxiety Disorders Historic Market Scenario in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 33: French Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 34: Anxiety Disorders Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 35: German Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 36: German Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 37: Italian Anxiety Disorders Market Growth Prospects in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 38: Anxiety Disorders Historic Market Analysis in Italy in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 39: Italian Anxiety Disorders Market by Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 40: United Kingdom Market for Anxiety Disorders: Annual Sales Estimates and Projections in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 41: Anxiety Disorders Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapeutic Type for the Period 2009-2017
    • TABLE 42: United Kingdom Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 43: Spanish Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025
    • TABLE 44: Spanish Anxiety Disorders Historic Market Review by Therapeutic Type in US$ Million: 2009-2017
    • TABLE 45: Anxiety Disorders Market in Spain: Percentage Share Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 46: Russian Anxiety Disorders Market Estimates and Projections in US$ Million by Therapeutic Type: 2018 to 2025
    • TABLE 47: Anxiety Disorders Market in Russia by Therapeutic Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 48: Russian Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018-2025
    • TABLE 50: Anxiety Disorders Market in Rest of Europe in US$ Million by Therapeutic Type: A Historic Review for the Period 2009-2017
    • TABLE 51: Rest of Europe Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 52: Asia-Pacific Anxiety Disorders Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 53: Anxiety Disorders Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 54: Asia-Pacific Anxiety Disorders Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 55: Anxiety Disorders Market in Asia-Pacific by Therapeutic Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 56: Asia-Pacific Anxiety Disorders Historic Market Scenario in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 57: Asia-Pacific Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 58: Anxiety Disorders Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 59: Australian Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 60: Australian Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 61: Indian Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025
    • TABLE 62: Indian Anxiety Disorders Historic Market Review by Therapeutic Type in US$ Million: 2009-2017
    • TABLE 63: Anxiety Disorders Market in India: Percentage Share Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 64: Anxiety Disorders Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 65: South Korean Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 66: Anxiety Disorders Market Share Distribution in South Korea by Therapeutic Type: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 67: Rest of Asia-Pacific Market for Anxiety Disorders: Annual Sales Estimates and Projections in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 68: Anxiety Disorders Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapeutic Type for the Period 2009-2017
    • TABLE 69: Rest of Asia-Pacific Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 70: Latin American Anxiety Disorders Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 71: Anxiety Disorders Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 72: Latin American Anxiety Disorders Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 73: Latin American Anxiety Disorders Market Growth Prospects in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 74: Anxiety Disorders Historic Market Analysis in Latin America in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 75: Latin American Anxiety Disorders Market by Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 76: Argentinean Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018-2025
    • TABLE 77: Anxiety Disorders Market in Argentina in US$ Million by Therapeutic Type: A Historic Review for the Period 2009-2017
    • TABLE 78: Argentinean Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 79: Anxiety Disorders Market in Brazil by Therapeutic Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 80: Brazilian Anxiety Disorders Historic Market Scenario in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 81: Brazilian Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 82: Anxiety Disorders Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 83: Mexican Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 84: Mexican Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 85: Rest of Latin America Anxiety Disorders Market Estimates and Projections in US$ Million by Therapeutic Type: 2018 to 2025
    • TABLE 86: Anxiety Disorders Market in Rest of Latin America by Therapeutic Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 87: Rest of Latin America Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 88: The Middle East Anxiety Disorders Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 89: Anxiety Disorders Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 90: The Middle East Anxiety Disorders Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 91: The Middle East Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025
    • TABLE 92: The Middle East Anxiety Disorders Historic Market by Therapeutic Type in US$ Million: 2009-2017
    • TABLE 93: Anxiety Disorders Market in the Middle East: Percentage Share Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025
  • IRAN
    • TABLE 94: Iranian Market for Anxiety Disorders: Annual Sales Estimates and Projections in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 95: Anxiety Disorders Market in Iran: Historic Sales Analysis in US$ Million by Therapeutic Type for the Period 2009-2017
    • TABLE 96: Iranian Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 97: Israeli Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018-2025
    • TABLE 98: Anxiety Disorders Market in Israel in US$ Million by Therapeutic Type: A Historic Review for the Period 2009-2017
    • TABLE 99: Israeli Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 100: Saudi Arabian Anxiety Disorders Market Growth Prospects in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 101: Anxiety Disorders Historic Market Analysis in Saudi Arabia in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 102: Saudi Arabian Anxiety Disorders Market by Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 103: Anxiety Disorders Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 104: United Arab Emirates Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 105: Anxiety Disorders Market Share Distribution in United Arab Emirates by Therapeutic Type: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 106: Anxiety Disorders Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025
    • TABLE 107: Rest of Middle East Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017
    • TABLE 108: Rest of Middle East Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 109: African Anxiety Disorders Market Estimates and Projections in US$ Million by Therapeutic Type: 2018 to 2025
    • TABLE 110: Anxiety Disorders Market in Africa by Therapeutic Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 111: African Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBOTT LABORATORIES
  • ALLERGAN PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • NOVEN PHARMACEUTICALS, INC.
  • PFIZER, INC
  • SHIONOGI & CO., LTD.
  • SUMITOMO DAINIPPON PHARMA CO.

V. CURATED RESEARCH

Back to Top